The results are now being published in Cancer Research and are part of a project funded by the Austrian Science Fund FWF. The antibodies produced during the project belong to a class that also plays a key role in the development of allergic reactions. Consequently, the results will be a key focal point at the 1st International AllergoOncology Symposium, which is to be held today in Vienna, Austria.
People who suffer from allergies are well acquainted with immunoglobulin E (IgE). It is this class of antibodies that plays a key role in causing an allergy sufferer's immune system to overreact. Oncologists too are very familiar with IgE. Numerous in-depth studies have shown that those with raised levels of IgE are much less likely to suffer from certain types of cancer. Or in other words – allergy sufferers are at a lower risk of developing cancer.
ALLERGY & CANCER
"In actual fact, the IgE produced during an allergic reaction does not attack cancer tumours but instead attacks allergens, for example pollen", explains the study's leader, Prof. Erika Jensen-Jarolim, head of the Department of Pathophysiology at the Medical University of Vienna. "The fact that IgE nevertheless acts against tumours is more of a fortunate side-effect of the highly efficient characteristic of this antibody class. It was our aim to make this antibody class, which is typical for allergies, act directly against tumours. At the same time, we wanted to encourage the long-term production of IgE in the body by means of active immunisation."
Prof. Jensen-Jarolim's group recently succeeded in achieving the latter – active immunisation against certain types of tumour – in mice. However, due to the selected type of immunisation (injection below the abdominal wall) the antibodies that were produced belonged to the IgG class. This type of antibody produces a much more limited and shorter-term effect against tumours than IgE antibodies.
THROUGH THE STOMACH
Prof. Jensen-Jarolim used one of her group's earlier successes – achieved as part of another FWF project on food allergies – to ensure that immunisation resulted in the intended activation of IgE. These findings prove that food proteins are effective in inducing IgE-dependent immune reactions when they withstand the acidic environment of the stomach.
Prof. Jensen-Jarolim's team therefore fed mice a peptide very similar to a tumour peptide while reducing acidification in the stomach, thereby hindering digestion of the peptide. As a result, a type of allergic reaction was triggered against this tumour-like peptide – the mice produced tumour-specific IgE antibodies. The result is the world’s first active IgE-stimulating tumour vaccination.
From Prof. Jensen-Jarolim's point of view, the publication of this work in Cancer Research comes at a the perfect time – just as the 1st International AllergoOncology Symposium starts on 16th April in Vienna. This symposium, which she initiated and organised, will be the first time that specialists from the U.K., France, Italy, Canada, Austria and the U.S. have been brought together to analyse and discuss the links between allergies and cancer. The topics under discussion range from the use of allergic reactions to treat cancer to the application of mimotopes for active immunisation against cancer tumours. By providing ongoing support for their work, the FWF has also helped establish this new medical field in Austria and on a global scale.
Image and text will be available online from Monday, 16th April 2007, 09.00 a.m. CET onwards: http://www.fwf.ac.at/en/public_relations/press/pv200704-en.html
Till C. Jelitto | alfa
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences